Why did Moody’s downgrade US credit rating?
How will tariffs impact US and European economy?
What caused 23andMe bankruptcy and acquisition?
Why is Nvidia expanding AI infrastructure in Taiwan?
How will Capital One’s Discover acquisition affect customers?
What’s behind the comeback of SPAC deals?
Why did CBS News CEO resign amid Trump lawsuit?
How are mortgage rates reacting to US credit downgrade?
What’s driving recent volatility in Bitcoin and crypto?
23andMe sells gene-testing business to DNA drug maker Regeneron
latimes.com/business/story/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneronBankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.
This story appeared on latimes.com, 2025-05-19 13:33:09.